ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Chinese Produced ASO Drug Innovation Therapy for Functional Cure of Chronic Hepatitis B Has Obtained FDA Clinical Approval
September 08, 2023Recently, Haobo Pharmaceuticals announced that their investigational antisense oligonucleotide (ASO) drug AHB-137 has received clinical trial approval from the FDA in the United States for use in patients with chronic hepatitis B. -
Empirico, Ionis collaborate to develop antisense oligonucleotide therapeutics
January 14, 2020Empirico has entered into a $660m deal with Ionis Pharmaceuticals to develop novel antisense oligonucleotide therapeutics. Under the three-year collaboration, Empirico will use its Precision Insights Platform to determine therapeutic targets for indicatio -
NICE recommends Akcea's Tegsedi for rare, life-threatening progressive disease
April 23, 2019NICE recommends Akcea's Tegsedi for rare, life-threatening progressive disease
Pharma Sources Insight January 2025
